Acolbifene Explained

Acolbifene (developmental code names EM-652, SCH-57068) is a nonsteroidal selective estrogen receptor modulator (SERM) which, as of 2015, is in phase III clinical trials for the treatment of breast cancer.^{[1] [2]}

See also

• Acolbifene/prasterone
• List of investigational sex-hormonal agents § Estrogenics

External links

• Acolbifene - AdisInsight

Notes and References

1. Gauthier S, Cloutier J, Dory YL, Favre A, Mailhot J, Ouellet C, Schwerdtfeger A, Mérand Y, Martel C, Simard J, Labrie F . 6 . Synthesis and structure-activity relationships of analogs of EM-652 (acolbifene), a pure selective estrogen receptor modulator. Study of nitrogen substitution . Journal of Enzyme Inhibition and Medicinal Chemistry . 20 . 2 . 165–77 . April 2005 . 15968821 . 10.1080/14756360500043448 . 45909360 .
2. Web site: Acolbifene - Endoceutics . Adis Insight . Springer Nature Switzerland AG .